Camp Lejeune cancer lawsuit

Marines With Cancer And Survivors Look Forward to Bellwether Trials This Year

Such trials may pave the way to expand the list of types of cancer that qualify for compensation

Tuesday, March 12, 2024 - Bellwether Camp Lejeune water lawsuits scheduled for 2024 may determine if the expanded list of cancers that may have been caused by drinking the water there may be expanded. Before the CDC study went public it might have been more difficult for people whose illnesses are not on the presumption list to get compensation under the Camp Lejeune Justice Act. In certain situations, they might have to sue in order to seek justice and get the money they are due. Effective navigation of the sometimes convoluted and protracted litigation process necessitates legal knowledge and resources. Most have sought the guidance of a Camp Lejeune water attorney to make sure they cover all of their bases. The choice to bring legal action should be well thought out, balancing the possible rewards against the risks and expenses involved. For many victims of Camp Lejeune water poisoning, going to court may be their only option to hold those responsible for their suffering accountable and recover damages, even if it can be emotionally and monetarily draining.

To recap, the U.S. Marine Corps post in North Carolina, Camp Lejeune, experienced a catastrophic contaminated water situation. The victims received justice and compensation thanks to the Camp Lejeune Justice Act of 2012. By enacting the act, the base's drinking water supply was contaminated with harmful substances between 1953 and 1987, which led to health problems. Cancer sticks out as a particularly serious concern among the many health issues that have been reported by former residents and staff of Camp Lejeune. According to the statute, there is a probable connection between the tainted water at Camp Lejeune and specific types of cancer. This implies that there is no need to establish a direct causal connection between the tainted water and the illness in order for a former resident or military member to be eligible for compensation under the act if they gets one of the designated malignancies. The presumed list's precise cancer kinds are restricted, nevertheless, mostly because of the scientific data that was available when the act was passed. The Veterans Administration (VA) lists cancers for which there is sufficient scientific and medical evidence to support a presumptive connection to the contaminated water at Camp Lejeune. These include adult leukemia, bladder cancer, kidney cancer, liver cancer, multiple myeloma, non-Hodgkin's lymphoma, and Parkinson's disease. The Camp Lejeune Justice Act uses this list as a guide to determine who is eligible for compensation. However, the list of presumed tumors may need to be updated and enlarged as new information becomes available and scientific understanding advances. The Centers for Disease Control and Prevention (CDC) have identified more cancer forms that could be linked to Camp Lejeune's tainted water after conducting a recent study. These comprise tumors of the myeloid type, cancers of the esophagus, larynx, thyroid, soft tissues, marginal B-cell lymphoma, specific lung cancers, and even breast cancer in men.

Information provided by CampLejeuneJusticeActClaim.com, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.